Copeptin, a Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal Dominant Polycystic Kidney Disease | Zendy

Esther Meijer | Zendy; Stephan J. L. Bakker | Zendy; Eric J. van der Jagt | Zendy; Gerjan Navis | Zendy; Paul E. de Jong | Zendy; Joachim Struck | Zendy; Ron T. Gansevoort | Zendy

Open Access

Copeptin, a Surrogate Marker of Vasopressin, Is Associated with Disease Severity in Autosomal Dominant Polycystic Kidney Disease

Author(s) -

Esther Meijer,

Stephan J. L. Bakker,

Eric J. van der Jagt,

Gerjan Navis,

Paul E. de Jong,

Joachim Struck,

Ron T. Gansevoort

Publication year - 2010

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.04560510

Subject(s) - copeptin , medicine , autosomal dominant polycystic kidney disease , urine osmolality , endocrinology , vasopressin , albuminuria , renal function , renal blood flow , nephrology , urinary system , urology , kidney

Experimental studies suggest a detrimental role for vasopressin in the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD). However, it is unknown whether endogenous vasopressin concentration is associated with disease severity in patients with ADPKD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research